|
Home
|
Issues
|
MJA shop
|
MJA Careers
|
Contact
|
Topics
|
Search
|
RSS |
→ Contents list for this issue
→ More articles on Biochemistry
→ More articles on Orthopaedic surgery
→ Search PubMed for related articles
Click to Login
Hide the Login Box
→ Click here for subscription options
A 77-year-old man with no significant medical history presented to the orthopaedic clinic of a metropolitan hospital with longstanding left mechanical knee pain. Examination and x-ray revealed features consistent with degenerative arthritis (Figure, A), and he subsequently underwent total knee arthroplasty. During surgery, a bluish-black pigmentation of the bone and the cartilage of the knee joint was noted (Figure, B). The patient’s surgery and recovery were uneventful. It was later discovered that he had a previously undiagnosed rare metabolic disorder, alkaptonuria, which affects one in 250 000 to 1 000 000 people worldwide.1
Alkaptonuria was one of the first inborn errors of metabolism to be described, in 1908.2 It is caused by mutations in the homogentisate 1,2-dioxygenase (HGD) gene, which results in a deficiency of HGD, which catabolises homogentisic acid (HGA). This leads to accumulation and deposition of HGA in cartilaginous tissues, causing a bluish-black discolouration (ochronosis).3 Ochronosis is generally asymptomatic, but ochronotic arthropathy due to deposition of pigments in the joints is common.3
The patient also had the characteristic ochronotic discolouration in the sclera (Figure, C), ear cartilage, fingernails and buccal mucosa, but did not report dark urine. The gene defect was not further investigated because of his age and excellent premorbid health status.
1 Goulburn Valley Health, Shepparton, VIC.
2 St Vincent’s Health, Melbourne, VIC.
7th.elementATgmail.com
|
Home
|
Issues
|
MJA shop
| Terms of use
|
MJA Careers
|
More...
|
Contact
|
Topics
|
Search
|
RSS |
©The Medical Journal of Australia 2009 www.mja.com.au PRINT ISSN: 0025-729X ONLINE ISSN: 1326-5377